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A single 2-g dose of tinidazole is the best 
treatment (strength of recommendation 
[SOR]: A, based on meta-analysis). 
Other drugs, such as nitazoxanide, 
metronidazole, mebendazole, and 
albendazole, can also be used (SOR: A, 
based on randomized controlled trial 
[RCT] of patient-oriented outcomes), 
but tinidazole has a higher clinical 
cure rate than these drugs. It also has 
a comparable side-effect profi le and 
requires only 1 dose. 
Evidence-based answer
Clinical commentary
The real challenge is diagnosis 
As this review points out, all the available 
treatments for giardiasis are effective. 
Additional prescribing considerations 
include cost (500 mg metronidazole costs 
about 30 cents, for example, while 2 
mg tinidazole costs $18) and insurance 
coverage. Tinidazole and metronidazole, 
unlike the other medications, require that 
the patient  abstain from alcohol for 72 
hours after dosing. 
 In my experience, the biggest 
challenge in treating giardiasis is deciding 
when to consider it in the differential and 
when to test for it. Presentations vary 
from vague symptoms such as bloating 
to severe diarrhea. Often the patient 
has not been exposed to well or stream 
water. You can test stool samples for ova 
and parasites, or serum for fl uorescent 
antibody or enzyme-linked immunosorbent 
assay (ELISA). 
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Prescribing 
considerations 
include cost: 
❙  500 mg 
metronidazole 
costs 30 cents 
❙  2 mg 
tinidazole 
costs $18 
❚ Evidence summary
Giardia lamblia is a protozoan para-
site found worldwide. Infection typi-
cally results from ingesting cysts in 
contaminated food or water. Patients 
with giardiasis may be asymptomatic 
or have mild to severe gastrointestinal 
symptoms, including explosive diar-
rhea, abdominal pain, steatorrhea, fl at-
ulence, bloating, nausea, and vomiting. 
Treatment varies widely based on geo-
graphic location, physician preference, 
and availability and cost of medication 
(TABLE).1
Tinidazole is the 
treatment of choice
A 2006 Cochrane Review compared 34 
trials of many drug therapies for giardia-
sis.2 The review, which is being updated 
to include additional publications, evalu-
ated both head-to-head and placebo-con-
trolled studies, looking at dosage as well 
as length of drug therapy.
The review found that a single dose of 
tinidazole had a higher clinical cure rate 
than other therapies such as metronidazole 
(odds ratio [OR]=5.33; 95% confi dence 
interval [CI], 2.66-10.67)2 along with a 
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comparable side-effect profi le. These fi nd-
ings favor tinidazole as the treatment of 
choice for symptomatic giardiasis. 
How effective are other drugs?
The 2006 Cochrane Review found no 
difference in clinical cure rate between 
short-term treatment (3 days) with 
metronidazole and longer therapy with 
metronidazole or other drugs. Subse-
quently, a single dose of metronidazole 
was found to be as effective as treatment 
for 5 days or longer (OR=0.33, 95% CI 
0.08-1.34). 
Since publication of the Cochrane 
review, several studies have further evalu-
ated mebendazole. 
• An RCT in Cuban children 5 to 15 
years of age found no difference in clini-
cal cure rate between a 5-day course of 
mebendazole and more traditional thera-
py with quinacrine.3 
• Another RCT comparing 5 days of 
mebendazole with 7 days of metronida-
zole in 7- to 12-year-old Iranian children 
showed no statistical difference in micro-
biologic cure between the 2 regimens.4
• Single-dose tinidazole was superior 
to 3 doses of mebendazole in a single day 
in an RCT of 122 Cuban children that 
measured microbiologic cure (NNT=5.5 
patients with tinidazole vs mebendazole).5 
Two RCTs found nitazoxanide to 
be effective (number needed to treat 
[NNT]=1.82) compared to placebo in 
adolescents and adults.6 A 3-day course of 
nitazoxanide was as effective as 5 days of 
metronidazole (80% vs 85%, P=0.61) in 
resolving clinical giardiasis.7 
An RCT of albendazole, 400 mg for 
5 days, in 28 adults found it to be as ef-
fective as 500 mg metronidazole given 
3 times a day for 5 days (80% vs 83%) 
but less likely than metronidazole (2% vs 
18%) to cause anorexia (number needed 
to harm [NNH]=6.25).
Recommendations
The Centers for Disease Control and 
Prevention recommends tinidazole, met-
ronidazole, quinacrine, albendazole, or 
nitazoxanide to treat giardiasis; how-
ever, it doesn’t indicate a preference for 
1 medicine over another.1 The Infec-
tious Diseases Society of America has 
no guideline. The Sanford Guide to An-
timicrobial Therapy recommends either 
a single 2-g dose of tinidazole or 500 mg 
of nitazoxanide PO bid for 3 days as pri-
mary treatment.8 ■
The biggest
challenge in 
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Drugs commonly used to treat giardiasis
DRUG ADULT DOSE SCHEDULE COMMENT
Tinidazole 2 g 1 time Can be given to children 3 years of age and older
   Pregnancy drug class C
Metronidazole 250, 500, 1 time or 3  Contraindicated in fi rst trimester of pregnancy
  or 750 mg times daily for 
  5 days. (Usually 
  250 mg, 3 times 
  a day, for 5 
  days) 
Mebendazole 100 mg  Twice daily  Contraindicated in fi rst trimester of pregnancy 
  for 5 days Pregnancy drug class B
Nitazoxanide 500 mg Twice daily  Can be given to children 1 year of age and older
  for 3 days  Available in liquid form
Pregnancy drug class B
Albendazole 200-400 mg Twice daily  Pregnancy drug class C
  for 5 days 
Sources: Beach M,1 and Gilbert DM et al.8
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